Star Combo Pharma Ltd Cash Flow Reinvestment Rate
Star Combo Pharma Ltd cash flow reinvestment rate. Star Combo Pharma Ltd (S66) has a Cash Flow Reinvestment Rate of 0.51x as of December 2025, reinvesting AU$295.53K (capex AU$295.53K ) from operating cash flow of AU$575.23K. See Star Combo Pharma Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Star Combo Pharma Ltd (2016–2025)
Cash flow reinvestment rate of Star Combo Pharma Ltd from 2016 to 2025. Historical reinvestment intensity for Star Combo Pharma Ltd across 6 annual periods. Explore Star Combo Pharma Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Star Combo Pharma Ltd Cash Flow Reinvestment Rate by Year (2016–2025)
Star Combo Pharma Ltd cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Star Combo Pharma Ltd. For the full cash flow conversion analysis, see Star Combo Pharma Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | AU$393.72K | AU$11.94 Million | AU$393.72K | ▼ -99.0% |
| 2023 | 3.17x | AU$5.96 Million | AU$1.88 Million | AU$2.73 Million | ▼ -97.6% |
| 2022 | 130.24x | AU$11.35 Million | AU$87.11K | AU$7.29 Million | ▲ +192.1% |
| 2021 | 44.59x | AU$14.78 Million | AU$331.53K | AU$7.26 Million | ▲ +15817.9% |
| 2017 | 0.28x | AU$261.13K | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.15 Million | AU$1.30 Million | AU$1.15 Million | — |